IVF Booster Offered in Canada But Not US
By Alison Motluk,
Canadian Medical Association Journal
| 01. 14. 2015
[Quotes CGS's Marcy Darnovsky]
Untitled Document
A new fertility treatment that purports to help older women get pregnant by boosting the energy in their eggs is now being offered in Toronto, but nowhere else in North America. A trial in the US was voluntarily suspended after the Food and Drug Administration suggested the treatment may be considered an "investigational new drug" requiring approval. In Canada, it may fall outside regulation, though Health Canada has not made any formal response to date.
The treatment, called Augment, involves extracting mitochondria, a cell's energy supply, from a woman's own ovarian stem cells and injecting them into her eggs during in vitro fertilization. In December 2014, OvaScience, the US-based company that developed Augment, announced that the treatment would be offered commercially. No clinical data on efficacy were provided, though they noted that 150 women had been enrolled in experimental trials at four sites worldwide. These include the Toronto Centre for Advanced Reproductive Technology (TCART) and clinics in London, Istanbul and Dubai. Company Chief Executive Officer Michelle Dipp said they expected Augment would be used in approximately 1000 paying patients in 2015....
Related Articles
By Gilma Avalos, NBC | 07.03.2024
Image by Josh Appel from Unsplash
The dream of becoming parents is turning into a nightmare for hundreds of people caught up in a surrogacy money scandal.
Some of the individuals are facing infertility or medical challenges, seeing surrogacy as...
By Emma McDonald Kennedy
| 07.11.2024
Louise Perry’s recent article in The Spectator cautions against “The quiet return of eugenics,” a threat she locates in preimplantation genetic testing for polygenic disorders. The technology is billed as a way for parents undergoing IVF to select which embryo to implant based on information about each embryo’s genetic risk factors and traits. These reports, she says, give parents “a very full picture of the adult that embryo could become”––from their child’s risk of developing different diseases to their “likely...
By Sonia Suter and Naomi Cahn, PET | 07.01.2024
Image by Dusdn5959 from Wikimedia Commons
Since the US Supreme Court's 2022 decision to overturn Roe v Wade (see BioNews 1147), there have been worries about the future of IVF in the USA. Both abortion and IVF involve decisions...